In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 2, 2016, Pages 510-516

  Singh, Gurinder ^a   Pai, Roopa S ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; In situ perfusion; Pharmacokinetic study; Polymeric precipitation inhibitor

Indexed keywords

BIOCHEMISTRY; DRUG DOSAGE; PHARMACOKINETICS; X RAY DIFFRACTION;

BIOAVAILABILITY; DRUG DELIVERY SYSTEM; EFFECTIVE PERMEABILITY; HYDROXYPROPYL METHYLCELLULOSE; LONG TERM STABILITY; ORAL BIOAVAILABILITIES; PHARMACOKINETIC STUDIES; PRECIPITATION INHIBITORS;

RESVERATROL;

DIETHYLENE GLYCOL MONOETHYL ETHER; HYDROXYPROPYLMETHYLCELLULOSE; LONG CHAIN TRIACYLGLYCEROL; RESVERATROL; TRANS RESVERATROL; TRANSCUTOL P; UNCLASSIFIED DRUG; DRUG CARRIER; EMULSION; NANOMATERIAL; STILBENE DERIVATIVE; TRIACYLGLYCEROL; WATER;

ANIMAL EXPERIMENT; APPARENT PERMEABILITY; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; ENTEROHEPATIC CIRCULATION; FRACTION ABSORBED; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOEMULSION; NONHUMAN; PRECIPITATION; RAT; SUPERSATURABLE SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; X RAY DIFFRACTION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; EMULSION; INTESTINE ABSORPTION; MEDICINAL CHEMISTRY; METABOLISM; SOLUBILITY; WISTAR RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EMULSIONS; HYPROMELLOSE DERIVATIVES; INTESTINAL ABSORPTION; MALE; NANOSTRUCTURES; RATS; RATS, WISTAR; SOLUBILITY; STILBENES; TRIGLYCERIDES; WATER;

EID: 84964336256     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.966192     Document Type: Article

References (24)

1. Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, et al. 2009. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res. 53:S7-15.
2. Amri A, Chaumeil JC, Sfar S, Charrueau C. 2012. Administration of resveratrol: What formulation solutions to bioavailability limitations. J Control Release. 158:182-193.
3. Amri A, Le Clanche S, Thérond P, Bonnefont-Rousselot D. 2013. Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death. Eur J Pharm Biopharm doi:10.1016/j.ejpb.2013.10.015.
4. Balakrishnan P, Lee BJ, Oh DH 2009. Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 72:539-545.
5. Bandyopadhyay S, Katare OP, Singh B. 2014. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv. 11:479-492.
6. Brouwers J, Brewster ME, Augustijns P. 2009. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 98:2549-2572.
7. Elsheikh MA, Elnaggar YSR, Gohar EY, Abdallah OY 2012. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine. 7:3787-3802.
8. Gao P, Morozowich W. 2006. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 3:97-110.
9. Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, Surapaneni S. 2009. Characterization and optimization of AMG 517 supersaturatable selfemulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci. 98:516-528.
10. Hung CF, Chen JK, Liao MH, Lo HM, Fang JY 2006. Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol. 6:2950-2958.
11. Johnson DA, Amidon GL 1998. Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J Theor Biol. 131:93-106.
12. Kim S, Na WK, Dong Y, Das S, Tan RBH. 2012. Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng. 10:37-42.
13. Marier JF, Vachon P, Gritsas A. 2002. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther. 302:369-373.
14. Nam JB, Ryu JH, Kim JW, Chang IS, Suh KD 2005. Stabilization of resveratrol immobilized in monodisperse cyano-functionalized porous polymeric microspheres. Polymer. 46:8956-8963.
15. Porter CJ, Charman WN 2001. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 50:61-80.
16. Singh G, Pai RS 2014a. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol 380 with enhanced bioavailability potential. Expert Opin Drug Deliv. 11:647-659.
17. Singh G, Pai RS 2014b. Trans-resveratrol self nano-emulsifying drug delivery systems 336 (SNEDDS) with enhanced bioavailability potential: Optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv. doi:10.3109/10717544.2014.885616.
18. Singh G, Pai RS 2014c. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS. J Control Release. 194:178-188.
19. Singh G, Pai RS, Pandit V. 2014. In vivo pharmacokinetic applicability of a simple and validated HPLC method for orally administered trans-resveratrol loaded polymeric nanoparticles to rats. J Pharm Investig. 44:69-78.
20. Tadros T. (2009). Polymeric surfactants in disperse systems. Adv Colloid Interface Sci. 147-148:281-299.
21. Thomas N, Holm R, Mullertz A, Rades T. 2012. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS). J Control Release. 160: 25-32.
22. Troche-Pesqueir E, Perez-Juste I, Navarro-Vazquez A, Cid MM 2013. Aβ-cyclodextrin-resveratrol inclusion complex and the role of geometrical and electronic effects on its electronic induced circular dichroism. RSC Adv. 3:10242-10250.
23. Wei Y, Ye X, Shang X, Peng X, Bao Q, Liu M, et al 2012. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A Physicochem Eng Asp. 396:22-28.
24. Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS 2013. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers. J Pharm Sci. 102:171-184.